Risk assessment: Outbreak of cholera in Cuba, potential risk for European travellers, 12 July 2012
This rapid risk assessment assesses the potential risk for European travellers to Cuba after an outbreak of cholera in the Granma Province of the country.
Rapid risk assessment: Public health risks related to communicable diseases during the hajj 2019, Saudi Arabia, 9–14 August 2019
In 2019, the hajj will take place between 9 and 14 August. The risk for EU/EEA citizens to become infected with communicable diseases during the 2019 hajj is considered low, thanks to the vaccination requirements for travelling to Makkah (Mecca) and the Saudi Arabian preparedness plans that address the management of health hazards during and after hajj.
- Food- and waterborne diseases
- Hepatitis A
- Hepatitis B
- Mass gathering
- Meningococcal disease
- Middle East respiratory syndrome coronavirus
- Public health threat
- Saudi Arabia
- Travellers' health
- Vaccine preventable diseases
- Vector-borne disease
Threat assessment brief: Outbreak of novel coronavirus disease 2019 (COVID-19): Situation in Italy
Outbreak of novel coronavirus disease 2019 (COVID-19): Situation in Italy
Increase of cases of Legionnaires’ disease in EU travellers returning from Dubai, October−December 2016
This report assesses the increase in travel-associated Legionnaires’ disease among returning EU travellers from Dubai, during October−December 2016.
Threat Assessment Brief: Pneumonia cases possibly associated with a novel coronavirus in Wuhan, China
Between 31 December and 5 January, 59 pneumonia cases possibly associated with a novel coronavirus have been reported in Wuhan, China with a common exposure link to Wuhan’s South China Seafood City market.
Rapid risk assessment: human infection with avian influenza A(H5N1) virus, Egypt, 23 December 2014
According to a WHO update published on 4 December 2014, eight new human cases of influenza A(H5N1) have been reported in Egypt, with onset of disease in November 2014, bringing the total for 2014 to 12.
Rapid Risk Assessment: Cluster of pneumonia cases caused by a novel coronavirus, Wuhan, China, 2020
A novel coronavirus (2019-nCoV) has been isolated and considered the causative agent of the cluster of 41 pneumonia cases in the area of Wuhan, Hubei province in China, as well as of the three travel-related cases in Thailand and Japan, arriving from Wuhan.
Risk assessment: Outbreak of acute respiratory syndrome associated with a novel coronavirus, Wuhan, China; first update
A novel coronavirus (2019-nCoV) has been isolated and considered the causative agent of the cluster of 448 pneumonia cases in the area of Wuhan, Hubei province in China, as well as of the four travel-associated cases in Thailand, Japan and South Korea.
Risk assessment: Outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): increased transmission beyond China – fourth update
On 31 December 2019, a cluster of pneumonia cases of unknown aetiology was reported in Wuhan, Hubei Province, China. On 9 January 2020, China CDC reported a novel coronavirus as the causative agent of this outbreak, which is phylogenetically in the SARS-CoV clade. The novel coronavirus has thus been named ‘severe acute respiratory syndrome coronavirus 2’ (SARS-CoV-2), while coronavirus disease associated with it is now referred to as COVID-19.
Rapid risk assessment: Outbreak of novel coronavirus disease 2019 (COVID-19): increased transmission globally – fifth update
As of 2 March, 66 countries have reported cases of of novel coronavirus disease 2019. The risk associated with COVID-19 infection for people in the EU/EEA and UK is currently considered to be moderate to high, based on the probability of transmission and the impact of the disease.